ODI Pharma AB (publ) (NGM: ODI)
Sweden flag Sweden · Delayed Price · Currency is SEK
2.760
0.00 (0.00%)
At close: Dec 20, 2024

ODI Pharma AB Revenue

ODI Pharma AB had revenue of 143.80K SEK in the quarter ending September 30, 2024, a decrease of -72.78%. This brings the company's revenue in the last twelve months to 22.06M, up 3,349.15% year-over-year. In the fiscal year ending June 30, 2024, ODI Pharma AB had annual revenue of 22.29M with 15,880.34% growth.

Revenue (ttm)
22.06M
Revenue Growth
+3,349.15%
P/S Ratio
1.96
Revenue / Employee
22.06M
Employees
1
Market Cap
43.22M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Jun 30, 202422.29M22.15M15,880.34%
Jun 30, 2023139.46K-173.48K-55.44%
Jun 30, 2022312.94K--
Jun 30, 2021---
Jun 30, 2020---
Jun 30, 2019 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition